Abstract: Isotonic, iso-osmotic, pH balanced thermoreversible gels are ideal vehicles for drug delivery to a body cavity of a mammal. The osmolality in the gel state can be calculated by assuming that a polyoxyalkylene block copolymer or polyether present in said gel does not contribute to the osmolality in the gel state, although it does contribute to the osmolality in the liquid state.

Abstract: A tooth whitening formulation comprising urea peroxide (1:1) in a concentration of 22-32% based on the total weight of the formulation, in combination with a gelling agent, is provided in accordance with the present invention. The invention also provides a method for whitening the teeth using said formulation wherein the formulation is applied to the teeth using a splint which keeps the formulation in contact with the teeth for a period of time sufficient to cause whitening thereof.

Abstract: A method for modifying the plastic surface of an article adapted for contacting living tissue by the gamma or electron beam irradiation induced chemical graft coating thereon of:(1) a neutral or ionic water-soluble, hydrophilic vinylic monomer or salt thereof;(2) a mixture of at least two of said monomers, or(3) a mixture of (1) or (2) with up to about 50%, by weight, based on the total monomer weight, of a member selected from the group consisting of N-vinylpyrrolidone, 2-hydroxyethyl-methacrylate, and mixtures thereof; so as to form a hydrophilic graft polymer coating on the surface.

Abstract: A color display facsimile of a cosmetic product comprised of the formulation of an original cosmetic product and prescribed amounts of each of a thermoplastic, copolymeric hardening agent and a hydrocarbonous-based temperature control component. The resultant display facsimile is capable of exhibiting the exact-likeness characteristics of true color, size, and shape of the original cosmetic product. The method for preparing said color display facsimile is also disclosed.

Abstract: Here is disclosed a water-insoluble pyrogen adsorbent composed of a polymer possessing amide groups optionally modified, said polymer being, e.g., a poly amino acid, a nylon, on a polyacrylamide.

Abstract: Dimethylpolysiloxane is effective for the treatment of gastritis.

Abstract: A hair protection film of the present invention aims at preventing and curing damage to the hair due to cold permanent wave treatment. The hair protection film for cold permanent wave treatment has a "sandwich" or three layer structure with a center layer coated on both sides with a protective layer. The center layer is formed of a film or a thin layer consisting mainly of at least one of "water-soluble natural sugar", "blood plasma", and "substitute blood plasma", or of a film or a thin film obtained by dispersing an extract of corn grains or a concentrate of brewage in polyvinyl alcohol. The protective layer that coats both surfaces is one of an alkali-soluble coating layer, an acid-soluble coating layer and a heat-soluble coating layer.

Abstract: Balanced pH, thermo-irreversible polyoxyalkylene polymer and ionic polysaccharide gels are ideal materials for use as an ablatable mask or coating over the cornea of the eye of a mammal during excimer laser keratectomy. The depth and smoothness of the ablated corneal surface can be controlled by molding the desired surface curvature into the mask surface using a contact lens as a mold which is pressed onto the gel surface coating the cornea.

Abstract: Sustained release pharmaceutical compound delivery compositions and methods for their production are disclosed wherein ion exchange resin particles are loaded with releasably bound pharmaceutical compounds prior to incorporation in an erodible polymeric matrix to form microparticulates. The microparticulates are suspended in a fluid medium where the encapsulating polymeric matrix shields the drug loaded ion exchange resin from solvent interaction. Administration to a target tissue site initiations erosion of the polymer matrix and release of the loaded pharmaceutical compound.

Abstract: Compressed molded preparations are disclosed. In the preparation coated granules of a pharmaceutical composition are compressed and molded together with non-coated component(s) containing 10% or more by weight of non-swelling polymers. According to the preparation there is little breakdown of the coating of coated granules at the time of compressing and molding, and the rate of disintegration, and in turn, the release rate of the pharmaceutical component, can be freely controlled or modulated.

Abstract: A stabilized solid controlled release dosage form having a coating derived from an aqueous dispersion of ethylcellulose is obtained by overcoating a substrate including a therapeutically active agent with an aqueous dispersion of ethylcellulose and then curing the coated substrate at a temperature and relative humidity elevated to a suitable level above ambient conditions until the coated dosage form attains a stabilized dissolution profile substantially unaffected by exposure to storage conditions of elevated temperature and/or elevated relative humidity.

Abstract: Therapeutic gels are provided which promote the healing of wounds and which have a minimum yield point of about 800 poise and a maximum apparent viscosity of about 100,000 cps, which gels comprise water, sodium chloride, and a gelling agent.

Abstract: A particle containing a liquid-soluble active substance for release outside a human or animal body, said particle comprising a core with a coating thereon, said coating comprising a liquid soluble active substance, is characterized in that the core has an appearance differing from the appearance of the coating, and that the appearance of the core is initially concealed by the coating and appears after dissolution of the liquid-soluble active substance, thus indicating that the active substance in said coating has been dissolved. The invention has its foremost application on granules, tablets and similar drug releasing units which make part of a parenteral liquid administration device.

Abstract: A pharmaceutical tablet is provided herein having an effective dissolution rate. The tablet contains a pharmaceutically-active ingredient and a substantially linear, i.e. non-crosslinked K-30 to K-120 PVP as a binding agent. The PVP used herein is made by an initiated polymerization process in which vinyl pyrrolidone monomer is polymerized in the presence of an initiator which produces a linear PVP polymerization, i.e. is a poor hydrogen abstractor of PVP polymer backbones, which would produce a disadvantageous crosslinked PVP product. Suitable initiators include low energy peroxyester free radical initiators, such as t-amylperoxy pivalate, an azo initiator, or a redox initiator which can perform at low temperatures.Preferably the residual initiator level in the PVP is reduced to less than 500 ppm, thereby further precluding the possibility of crosslinking of the PVP polymer during the shelf-life of the tablet.

Abstract: A highly palatable, low moisture non-baked cholestyramine composition has cholestyramine in stable admixture with a suitable carrier. The carrier is made up of a grain or flour, sugars and starch binder, and may also contain flavorings, preservative, and an edible oil. The cholestyramine composition should not have more than 11.0% moisture by total weight and the optimal moisture content is not more than 2.0 to 4.0% by weight or lower. The composition may be in the form of coarse granules similar to granola or wheat germ, as well as croutons or chewable tablets which may be consumed without beverages or other food products.

Abstract: Disclosed are gastric acid-resistant polymer-coated buffered-bile acid compositions, process for their preparations and methods of treating digestive disorders, impaired liver function, autoimmune diseases of the liver and biliary tract, prevention of colon cancer following cholecystectomy, cystic fibrosis, dissolving gallstones and regulating dietary cholesterol absorption by administering said compositions to a mammal in need of such treatment.

Abstract: The present invention concerns a process for preparing a treated blend which contains pigment material dispersed in a continuous phase of water and a polyester material. The invention also concerns compositions prepared from such process. The polyester material of the treated blend is linear, contains a sulfomonomer, and has an average particle size of less than 1 .mu.m.

Abstract: Thermoplastic molding compositions contain as essential componentsA) 40-95% by weight of a partly aromatic copolyamide composed essentially ofA.sub.1) 20-90% by weight of units derived from terephthalic acid and hexamethylenediamine,A.sub.2) 0-50% by weight of units derived from .epsilon.-caprolactam andA.sub.3) 0-80% by weight of units derived from adipic acid and hexamethylenediamine,B) 5-60% by weight of an impact modifying rubber, and in additionC) 0-50% by weight of fibrous or particulate fillers or mixtures thereof.